Skip to Content

Label Changes for:

Halcion (triazolam tablets)

February 2008

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- February 2008


The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.

Summary View


Sections Modified Summary of Changes to Contraindications and Warnings


  • Sleep Disturbances
  • Severe Anaphylactic and Anaphylactoid Reactions


  • Information for Patients
    • "Sleep-driving" and other Complex Behaviors
    • Drug Interactions
      • Drugs that inhibit triazolam metabolism via cytochrome P450 3A:
      • Ketoconzaole
      • Itraconazole
      • Nefazodone